Literature DB >> 9620241

Non conventional fractionation in radiotherapy of the musculo-skeletal sarcomas.

E Barbieri1, G Frezza, O Martelli, S Neri, M Mercuri, F Gherlinzoni, G Bacci, A Mancini, C Putti, L Babini.   

Abstract

In 1989 we started an accelerated hyperfractionated schedule of radiotherapy (two 1.6 Gy daily fractions) in standard risk localized Ewing's sarcoma of bone, with the aim at reducing late effects in young patients and at improving disease control through a better integration of treatment modalities. From 1991, the same schedule was used in preoperative radiotherapy of adult soft tissue sarcomas of the extremities: the main purpose was to reduce the time to surgery and to evaluate surgical complications in comparison with a previous experience of hypofractionated radiotherapy (one 3 Gy daily fraction). From 1991 to 1997, 76 patients with Ewing's sarcoma and 24 patients with soft tissue sarcoma were treated at our Institution. Results and complication rates are analyzed in comparison with historical data. In Ewing's sarcoma, a correct evaluation of improvement in local control was difficult because of changing treatment policy (bulky disease was not included in the present series). Late effects, as evaluated in patients with a minimum follow-up of 3 years, occurred with similar incidence, but at higher total dose levels in patients treated with accelerated hyperfractionation. In patients with soft tissue sarcomas, incidence of surgical complications is reduced as compared to historical experience. Major problems of wound healing were seen in association with intraoperative brachitherapy boost.

Entities:  

Mesh:

Year:  1998        PMID: 9620241     DOI: 10.1177/030089169808400213

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  1 in total

1.  Treatment of nonmetastatic Ewing's sarcoma family tumors of the spine and sacrum: the experience from a single institution.

Authors:  Gaetano Bacci; Stefano Boriani; Alba Balladelli; Enza Barbieri; Alessandra Longhi; Marco Alberghini; Katia Scotlandi; Cristiana Forni; Paola Pollastri; Daniel Vanel; Mario Mercuri
Journal:  Eur Spine J       Date:  2009-03-11       Impact factor: 3.134

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.